to contain disease causing
variants identifying disease causing
variants the disease causing / preventing
variants to characterise disease causing
variants the PNPLA1 disease causing
variants the absence of disease causing
variants affecting disease causing
variants inferring disease causing
variants those referenced disease causing
variants the frequency of the disease causing
variants genetic disease causing
variants severe disease causing
variants Finding disease causing
variants the prioritization of disease causing
variants 95 % of disease causing
variants two disease causing
variants most monogenic disease causing
variants the number of potential disease causing
variants interrogation of potential disease causing
variants discovering potential disease causing
variants the prioritisation of potential disease causing
variants the majority of known disease causing
variants to prioritize candidate disease causing
variants 8 possible disease causing
variants rare , recessive disease causing
variants Previously reported disease causing
variants 7 novel likely disease causing
variants seven novel likely disease causing
variants 9 novel potential disease causing
variants to investigate human disease causing
variants rare pathogenic disease causing
variants well - documented disease causing
variants clinically reportable disease causing
variants the discovery and analysis of disease causing
variants different underlying disease causing
variants The majority of these dominant disease causing
variants to distinguish between normal and disease causing
variants A total of 10 disease causing
variants a variety of inherited disease causing
variants Genetically edit all my disease causing
variants to the disease - risk ( D - variants contribute
to the disease - risk ( D - variants to disease resistance contributing
to disease resistance to the disease trait potentially contributing
to the disease trait risk to disease contribute
risk to disease rare diseases and complex traits causing
rare diseases and complex traits disease “ mutations cause
disease “ mutations disease progression influencing
disease progression to a specific disease contributing
to a specific disease disease course influencing
disease course to genetic disease contribute
to genetic disease to disease liability contributing
to disease liability Mendelian disease cause
Mendelian disease to rare disease phenotypes and Mendelian conditions contributing
to rare disease phenotypes and Mendelian conditions to misregulated gene expression and human disease lead
to misregulated gene expression and human disease to the development of common diseases like CD contribute
to the development of common diseases like CD to a loss of TREM2 function impair microglia signaling leading
to a loss of TREM2 function impair microglia signaling infantile - onset disease causing
infantile - onset disease the likelihood of developing disease influence
the likelihood of developing disease or modify disease in ALS cause
or modify disease in ALS disease or affect traits cause
disease or affect traits in isolation or in combination ... to a particular trait or disease could lead
in isolation or in combination ... to a particular trait or disease disease or increasing susceptibility to disease are causing
disease or increasing susceptibility to disease to breast cancer risk in our population contributing
to breast cancer risk in our population to complex traits ( 14 contributing
to complex traits ( 14 phenotypic variation causing
phenotypic variation or modify the phenotypes cause
or modify the phenotypes to adaptive phenotypes contribute
to adaptive phenotypes myopathic phenotypes influencing
myopathic phenotypes aberrant splicing in tumors may cause
aberrant splicing in tumors to a disease in the future ... with a certain probability might lead
to a disease in the future ... with a certain probability to a certain tendency to get this disease contribute
to a certain tendency to get this disease from genome - wide association studies ( GWAS discovered
from genome - wide association studies ( GWAS to loss of function of PLPBP leading
to loss of function of PLPBP to a complete loss of function lead
to a complete loss of function in loss of function of DSC2 resulting
in loss of function of DSC2 to breast cancer risk in Southern Finland contributing
to breast cancer risk in Southern Finland to help them apply across different scientific fields or different career stages [ 1 designed
to help them apply across different scientific fields or different career stages [ 1 in whole genome sequencing surveys and possible diagnostic analysis of disease gene subsets discovered
in whole genome sequencing surveys and possible diagnostic analysis of disease gene subsets in sequencing studies discovered
in sequencing studies other approaches as well to prevent
other approaches as well